Pillstats
Rx only · Injection, Solution · Intramuscular

Gentamicin Sulfate

Brands: Gentamicin · Gentamicin Sulfate

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US9 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)1596450
US makers6 labelers
Packages13
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.481$0.961$1.44$1.92Dec 2025Apr 2026Jul 2026
$1.368
Latest avg · Jul 22, 2026
-18%
Since Dec 17, 2025
6
Active US suppliers
62%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

4.9K9.7K15K19K2025 Q12025 Q22025 Q32025 Q42026 Q1
13K
Rx · 2026 Q1
174K
Units dispensed
-20%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Fresenius Kabi USA, LLCunknown5SUPPLYING
Medical Purchasing Solutions, LLCunknown3SUPPLYING
Henry Schein Inc.unknown2SUPPLYING
HF Acquisition Co LLC, DBA HealthFirstunknown1SUPPLYING
Cardinal Health 107, LLCunknown1SUPPLYING
Hospira, Inc.unknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Nov 12, 2014
    RECALLRecall (Class II): GENTAMICIN INJECTION, USP, equivalent to 40 mg/mL, Rx only, 20 mL Multiple Dose Vial, Manufactured by APP Pharmaceutica…

    Defective Container: Vials may be missing stoppers. — Recalling firm: Fresenius Kabi USA, LLC — Nationwide and Puerto Rico

  • May 2, 2013
    RECALLRecall (Class II): Gentamicin Sulfate Injection USP 80 mg/2 mL(40 mg/mL as Gentamicin), 2 mL Single-dose Fliptop Vial, (NDC 0409-1207-13),…

    Presence of Particulate Matter: visible particles were identified floating in the primary container. — Recalling firm: Hospira Inc. — Nationwide